chrisvoncsefalvay/vaers-outcomes huggingface dataset:
1 week After My 2nd dose , I feel abdominal cramps like My stomach is full of air and I have the urge to move My bowel like I?m having diarrhea. I can?t Control it. I?m honestly not sure if this was a side effect of the Vaccine but I didnt have this issue before I got the Vaccine.
Flu shot received on 10/21/2002. Initial medical exam on 11/04/2002: blood test initiated: no diagnosis made at time. Examined by neuroligist on 11/12/2002: diagnosed was Guillain-Barre Syndrome: more blood test. Continues normal activities when possible with assistance. Loss of reflexes. Test results unknown at this time
Pt wouldn't eat dinner and vomited. Had "small bumps" all over body, child itching on face, legs and trunk. Temperature of 100.2F, irritable and didn't sleep well. Small bumps started to fade. Had a poor appetite and mother brought child in on 5/2/01. Noted small round bumps, light in color. "Still has bumps".
I awoke the following day with a swollen shoulder with pain upon touch (as though terribly bruised), aching hips and the chills. The chills lasted most of the morning and the achiness most of the day.  The achiness passed the following day but that evening I developed a headache (throbbing in my right temple) that I treated with acetaminophen for three days.
No adverse event reported. Patient received Pfizer Bivalent 12+ in error instead of age appropriate Pfizer 5-11 product.
This is a spontaneous report based on the information received by Pfizer from Merck & Co., Inc. (manufacturer control number: 00271495). A contactable pharmacist reported for a patient of an unspecified age, race, ethnicity and gender who received a single dose of PREVNAR 13 via an unspecified route of administration on an unspecified date for immunization.  The patient medical history and concomitant medications were not reported.  After the vaccination the patient experienced hives. Outcome was unknown. No follow-up attempts are possible. No further information is expected.
Pt recvd 3 doses of Engerix-B 7JAN91, 7FEB91 & 11JUL91 & reporter indicated due to neg HBSAB titer result, 4th dose of Engerix-B was required 21SEP91;
This spontaneous prospective pregnancy report as received from a nurse refers to a 19 year old female patient. The patient's medical history included blood infection 5 years ago. On 19-SEP-2016, the patient was vaccinated with GARDASIL dose 2, (route: intramuscular) or GARDASIL 9 and later it was revealed that she was 9 weeks and 1 day pregnant as of today (17-OCT-2016). The reporter was unsure if the patient received GARDASIL or GARDASIL 9, because the vaccines were administered at a different physician's office and complete medical records were not available. On an unknown date, patient underwent pregnancy test, 2 ultrasounds, and routine pregnancy blood work (results were not specified). No adverse effects have been observed. The outcome of the events was unknown. Additional information has been requested.
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and gender. On an unknown date the unspecified number of patients were vaccinated with a total of five doses of improperly stored PROQUAD (Merck) (dose and route of administration were not reported, lot # K023364 with expiration date: 20-MAY-2016). It was also reported that on an unknown date five patients were administered improperly stored doses of VARIVAX (Merck) (captured in MARRS # 1504USA001740). Additional information has been requested.
rash at injection site about the size of a quarter; Itching like crazy; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE RASH (rash at injection site about the size of a quarter) and PRURITUS (Itching like crazy) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced INJECTION SITE RASH (rash at injection site about the size of a quarter) and PRURITUS (Itching like crazy). At the time of the report, INJECTION SITE RASH (rash at injection site about the size of a quarter) and PRURITUS (Itching like crazy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
Shoulder/upper arm soreness x 5 weeks, ongoing. Treatment with heat patches and NSAIDs.
pt recv vax 8NOV95 & 10NOV95 pt devel an abscess @ the inj site (described as hot & tender);pt was placed on ATB & was reportedly improving p/3 days;
Following #1 DTP pt had persistent, unusual high-pitch cry for 6 hrs;
Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 1/23/2021 and 3/2/2021. Presented to ED on 12/28/2021 with complaints of worsening shortness of breath for 3 days. Associated symptoms include dry cough, fever, chills, body aches, and nausea. Patient usually on 2-3L of oxygen a home. His oxygen level has dropped to 80s even with increasing oxygen to 4 L.  Patient was intubated on 12/30/2021 due to progressive ARDS. Underwent proning, lung protective vent strategy, and remdesivr treatment. On 1/9/2022 patient suffered 5 separate VT episodes for which he underwent automatic defibrillation from ICD.  Patient expired on 1/9/2022.
Extremely sore arm. Fatigue and diarrhea and nausea. On the 13th, I started getting a UTI and had a Doctor's appointment for the UTI on the 18th of January. Put me on an antibiotic. The antibiotic didn't resolve the symptoms - I was having pains off and on for about 6 weeks.  I went to my  Dr  - my OB, Feb 3 - did another Urinalysis - and that came out okay
loss of strength in left arm; no energy; bad pain/ whole left side of his body in pain; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (loss of strength in left arm), ASTHENIA (no energy) and PAIN (bad pain/ whole left side of his body in pain) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010A21A and 032L20A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes. Concomitant products included METFORMIN for an unknown indication.   On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MUSCULAR WEAKNESS (loss of strength in left arm), ASTHENIA (no energy) and PAIN (bad pain/ whole left side of his body in pain). At the time of the report, MUSCULAR WEAKNESS (loss of strength in left arm), ASTHENIA (no energy) and PAIN (bad pain/ whole left side of his body in pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood glucose: 97-423 (High) 97-423 Patient stated his blood sugar has been erratic.. On an unknown date, Glycosylated haemoglobin: 9.9 (High) 9.9, 7 (Inconclusive) 7 and 14 (High) A1C reaching over 14, but averaging at 5-9.9..     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient stated that before vaccination, A1C is about  6.3-6.5 No treatment medications provided by the reporter.      Most recent FOLLOW-UP information incorporated above includes: On 17-May-2021: Additional information received on 17MAY2021, contains no significant information. On 21-Jun-2021: Follow up received on 21-JUN-2021: Updated patient initial, Added  lab data and medical history , additional  events asthenia and pain were added. On 07-Jul-2021: Follow up received on 07JUL2021, contains non significant information.
Information has been received from a physician concerning a male pt who on 26Sep96 was vaccinated once with a 0.5ml SC dose of varicella virus vaccine live (lot 617911/0778D). On 18Jun05 the pt presented with a varicella breakthrough with less than 50 lesions. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. The pt's brother experienced a varicella breakthrough with less than 50 lesions following vaccination with varicella virus vaccine live (WAES0506USA03874). Additional information has been requested.
1 week after vaccine extreme dizziness and nausea. I am now going on a week and a half of nonstop dizziness and nausea and is only relieved with laying down and sleep. I am unable to work and barely able to do simple tasks around my home before having to lay down again.
fever, irritability & rash 7-10 days p/vax of MMR;
I had the Pfizer both the vaccines, then I had a booster. Then I got COVID; I had the Pfizer both the vaccines, then I had a booster. Then I got COVID; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), Suspected COVID-19 (medically significant), outcome "unknown" and all described as "I had the Pfizer both the vaccines, then I had a booster. Then I got COVID".  Additional Context: It was mentioned that yesterday, on 15Sep2022, patient got the second booster (Pfizer Covid 19 second booster shot) and at the same time they got the unspecified flu shot, one in one arm, one in the other. The patient asked if that was acceptable.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Red rash developed in the arm of the injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Red rash developed in the arm of the injection) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (Red rash developed in the arm of the injection). At the time of the report, VACCINATION SITE ERYTHEMA (Red rash developed in the arm of the injection) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Feb-2021, Body temperature: 98°f (High) 98°F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant information  provided. Treatment included Cold clothes on the rash.
Bilateral neuropathy.  Numbing & tingling in hands & feet.  Started approximately weeks after vaccination.  Sensitivity to cold & heat in both hands.
Moderna COVID-19 Vaccine EUA Day 9 after vaccination: injection site redness has returned and is now discolored in center, like a bruise surrounded by red. Additionally, itching returned on Day 7.
5/3/21 Pt felt itchy 15 min into obs period. Skin increased blotchiness on face and neck with increasing itchiness reported. No resp distress noted. Assisted to gurney for observation. Telephone order for 25 mg po Benadryl obtained.   1235 benadryl given with little relief after 20 min. BP 146/85 HR 60's-70's, awake, alert with no c/o throat swelling. But increasing discomfort due to hives. Team Alert called. Transported to ED via gurney by ED
Received vaccine 23 Jun that evening severe diarrhea followed by fever & vomiting, went to doc. 28 Jun. On quarters for 7 days. Able to eat 4 Jul for first time. Vomiting, nausea, diarrhea, fever, chills, fatigue.
DEVELOPED PERIPHERAL NEUROPATHY  1 WEEK AFTER COVID BOOSTER LASTED 3 WEEKS. NO ALTERNATIVE  CAUSE FOUND ON Workup
This spontaneous report as received from a medical assistant regarding a patient of unknown age and gender with no pertinent medical history reported. On 09-AUG-2013 the patient was vaccinated with a dose of PNEUMOVAX23 (lot number reported as 1502AA and expiration date 19-MAY-2013) (dose and route not specified). No other suspect therapies or concomitant medications were reported. The reporter stated that the patient was administered PNEUMOVAX23 from an expired vial. No adverse events were reported. The medical assistant reported that other three patients were administered with PNEUMOVAX23 from an expired vial (MARRS 1308USA005803 MARRS 1308USA005804 MARRS 1308USA005805). This is one from several reports from the same reporter. Additional information has been requested.
Dizziness, weakness, fatigue, malaise had Tdap and HPV #1 at 830 AM returned to clinic at 245 PM with above complaints was feeling good at time immunizations administered.
After the initial sore arm wore off after a day, I began experiencing extreme fatigue and malaise then sore throat, pressure in head, dull headache overall,  back pain, pulsatile tinnitus, joint pain, nausea and 2 days of diarrhea. I also had/have hot flashes and chills. Never, have I felt so sick for so long of a time in my life. Symptoms have continued over 2 weeks into the 3rd week now. and have lessened but the headache and head pressure and back pain and hot flashes continued. It is a feeling of malaise.  have been to my doctor's office 2 times and have had multiple blood work done in many many areas and a brain scan ( to rule out the possibility of a stroke). All negative except a Hepatitis B panel that showed that I do not have antibodies for Heptatitis B and the Doctor recommended that I get the 2 part Hepatitis B vaccination that I will do as soon as I feel better. I have never felt this poorly for so long. The only antecedent factor was the RSV vaccine.
itchiness; rash on hands and forearm; arm soreness; This spontaneous case was reported by a health care professional and describes the occurrence of VACCINATION SITE PAIN (arm soreness), PRURITUS (itchiness) and RASH (rash on hands and forearm) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hair dye sensitivity and Hay fever. Concomitant products included TAMSULOSIN HYDROCHLORIDE (FLOMAX RELIEF) for Enlarged prostate.    On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced VACCINATION SITE PAIN (arm soreness). On 03-Mar-2021, the patient experienced PRURITUS (itchiness) and RASH (rash on hands and forearm). On 04-Mar-2021, VACCINATION SITE PAIN (arm soreness) had resolved. At the time of the report, PRURITUS (itchiness) and RASH (rash on hands and forearm) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment included an unspecified steroid pack which made the patient feel better, but the symptoms did not go away.
Electrical shock sensation at time of injection. For 3 months since deep pain in arm, which has 3 weeks ago also in neck/shoulder.
Red spots not itchy; This case was reported by a consumer via interactive digital media and described the occurrence of erythema in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 21st August 2021, the patient received the 2nd dose of Shingrix. On 22nd August 2021, 1 days after receiving Shingrix, the patient experienced erythema. On an unknown date, the outcome of the erythema was unknown.   It was unknown if the reporter considered the erythema to be related to Shingrix.  Additional case details were reported as follows: The case was reported by the patient. Age at vaccination was not reported. The patient received Shingrix 2nd dose last Saturday and yesterday from the day of reporting developed red spots over body. The reporter said it was not itchy, also asked was this normal. No contact details were reported.
Sleepy; She couldn't get up, she had a horrible and "very strong" pain in her leg, soon it started in the other leg, like a "very strong cramp,"; She couldn't get up, she had a horrible and "very strong" pain in her leg, soon it started in the other leg, like a "very strong cramp,"; She felt the blood flow at a tremendous speed, from the waist down; It could be a circulation problem because of her varicose veins; It could be a circulation problem because of her varicose veins; she felt in her legs as if they had uncovered a sewer pipe and the water was squirting, she thinks she was probably dehydrated; This is a spontaneous report from Medical Information Team. A contactable consumer (patient) reported that a 82-year-old female patient received first dose of bnt162b2 (BNT162B2, Solution for injection) via unspecified route of administration on 20Apr2021 as single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. as per reported, She received the first dose on 20Apr2021, then went home and was very sleepy, she took a nap. When she woke up, she couldnt get up, she had a horrible and "very strong" pain in her leg, soon it started in the other leg, like a "very strong cramp," so she had to massage herself. She lived alone and when she got up, she felt the blood flow at a tremendous speed, from the waist down. After that she drank water and the feeling disappeared. She thought it could be a circulation problem because of her varicose veins, she takes aspirin. She thought her reaction the first time might have been vaccine-related, it was "horrifying, very strong," she felt in her legs as if they had uncovered a sewer pipe and the water was squirting, she thought she was probably dehydrated, so she was a little afraid to receive the second dose. However, now "I feel very good". Outcome of event Blood flow sensation was recovered on an unspecified date in 2021 and for remaining events its was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Four days after my first dose-bad joint pain in every thing I ever injured in my life ,got worse each day,then slowly better.
a little bit of soreness; a little bit of rash; This spontaneous case was reported by a consumer and describes the occurrence of PAIN and RASH in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN and RASH. At the time of the report, PAIN and RASH had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was unknown.       Concomitant medication of the patient was not reported.   The patient had adverse events, on the day of vaccination only.  No treatment information was provided by the reporter.   This case was linked to MOD-2021-410411 (Patient Link).
Extreme high temperature which caused delusions, heart rate went to 120 for over 24 hours, lips red and itchy, tongue numb.
After taking the Moderna booster shot after work around 6:00 PM at the Pharmacy, by the time I got to work the next morning at 8:00 AM I had heart palpitations, severe chest pain and trouble breathing. I immediately left work and my husband drove me to the local Emergency Room. The run an ekg and chest X-ray and tell me I am fine and send me home, saying that I had a bad reaction to the Moderna vaccine. On 2/13/2023, I?m rushed into the Same hospital ER for  the same reason heart palpitations, chest pains and trouble breathing and the hospital admitted me and I was in the cardiac unit for 48 hours. The heart doctor ran every test on my heart and said that I have myocarditis and pericarditis; due to having had Covid 19 three times in the last three years and then taken the Moderna shot three times caused the inflammation of my heart.
This retrospective pregnancy case was reported in a literature article and described the occurrence of spontaneous abortion in a female subject of unspecified age who was vaccinated with H1N1 (manufacturer unspecified). On an unspecified date, the subject received unspecified dose of H1N1 (unknown route, site of injection and batch number). Her last menstrual period was on an unspecified date and estimated date of delivery was not provided. The subject was exposed to the vaccine at an unspecified trimester. At an unspecified time after vaccination with H1N1 and prior to 20 week's gestation, the subject experienced spontaneous abortion. This case was assessed as medically serious by GSK. This case is linked to 27 other cases (related by publication). Summary of the article: The potential serious consequences of maternal influenza infection in pregnancy have long been recognized; pregnant women are at increased risk for influenza-associated morbidity and mortality. As reviewed recently, there are limited data on the safety of influenza vaccine in pregnancy; however, to date, there has been no indication that seasonal influenza vaccines containing inactivated virus pose a risk to the mother or the foetus. This has led to the current recommendation that all pregnant women be vaccinated with the seasonal influenza vaccine regardless of trimester. Despite these recommendations, vaccination rates remain less than optimal. Surveys have demonstrated that mother's concerns about safety contribute to poor compliance with vaccine recommendations. This situation was escalated during the 2009-10 H1N1 season, when lack of safety data about the H1N1 was coupled with intensive public health messaging that emphasized the need for all pregnant women to be vaccinated. Additional safety information on H1N1-containing vaccines when used in pregnancy was therefore needed. The purpose of this study was to evaluate the foetal risk and relative safety of the H1N1. To assess risks and relative safety of the H1N1-containing vaccines, the author conducted a prospective cohort study of H1N1-vaccine-exposed and unexposed comparison women who were recruited during pregnancy and followed to outcome between October 2009 and August 2012. There were 1032 subjects available for analysis; 841 women were exposed to a H1N1-containing vaccine in pregnancy, and 191 women were unexposed to any influenza vaccine in pregnancy. Nine of 328 (2.7%) first-trimester-exposed pregnancies resulted in an infant with a major birth defect compared to 6/188 (3.2%) in the unexposed. The hazard ratio (HR) for spontaneous abortion was not elevated. Adjusted HRs for preterm delivery were elevated for exposure anytime in pregnancy, specifically with exposure in the 1st or 2nd trimester. However, the mean decrease in gestational age in the exposed pregnancies was approximately three days. In conclusions, no meaningful evidence of increased relative risk or HR for major birth defects, spontaneous abortion, or small for gestational age infants was demonstrated.
In 6/98, the pt developed varicella and sought unspecified medical attention. No further information is available.